PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care System
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1165
https://www.valueinhealthjournal.com/article/S1098-3015(12)01230-2/fulltext
Title :
PCN48 Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01230-2&doi=10.1016/j.jval.2012.03.1165
First page :
A216
Section Title :
Cancer
Open access? :
No
Section Order :
685